Literature DB >> 12147240

Effects of hyperactive Janus kinase 2 signaling in mammary epithelial cells.

Hanne Olsen1, Malin A Hedengran Faulds, Pipsa Saharinen, Olli Silvennoinen, Lars Arne Haldosén.   

Abstract

Prolactin, the Janus kinase 2 (JAK2) and the signal transducer and activator of transcription 5 (STAT5) are important for mammary gland development and have also been implicated in development and growth of breast tumors. In the present study we have investigated the role for JAK2 in proliferation, differentiation, and apoptosis of the mammary epithelial cell line HC11 by stably overexpressing two hyperactive JAK2 mutants. Cells expressing a JAK2 mutant consisting of only the kinase domain had high amount of nuclear STAT5 protein with low DNA-binding activity, which was rapidly induced to a DNA-binding state by prolactin treatment. Cells expressing JAK2 deleted of the kinase-like domain showed increased sensitivity to prolactin treatment compared to wild type cells. Proliferation was not affected by any of the mutants whereas the ability to undergo apoptosis was decreased implicating a transforming potential of the JAK2 mutants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147240     DOI: 10.1016/s0006-291x(02)00847-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo.

Authors:  Marie-Stéphanie Clerget Froidevaux; Petra Berg; Isabelle Seugnet; Stéphanie Decherf; Nathalie Becker; Laurent M Sachs; Patrice Bilesimo; Maria Nygård; Ingemar Pongratz; Barbara A Demeneix
Journal:  EMBO Rep       Date:  2006-08-25       Impact factor: 8.807

2.  Ontological visualization of protein-protein interactions.

Authors:  Harold J Drabkin; Christopher Hollenbeck; David P Hill; Judith A Blake
Journal:  BMC Bioinformatics       Date:  2005-02-11       Impact factor: 3.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.